A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The objective of this study is to evaluate the immunogenicity and safety of SCTV01C in participants aged ≥12 years and previously fully immunized with inactivated COVID-19 vaccine.
Epistemonikos ID: 228df0c02eaa057e2717e8a81fb9cc910c9fe235
First added on: Feb 16, 2022